Emerging biotechnologies: full report - Nuffield Council on Bioethics

More documents

Recommendations

Info

E m e r g i n g b i o t e c h n o l o g i e s List of abbreviations AEBC BBSRC BIS BIVDA BPAA BPF DBF Defra DNA DTI EFSA EPSR ESBAC ESRC FDA FET FSA GDP GM GMO GNP GSK HEFCE hESC HFEA HGC HGP Agriculture and Environment Biotechnology Commission Biotechnology and Biological Sciences Research <strong>Council</strong> (Department of) Business, Innovation and Skills British In Vitro Diagnostics Association Best previously available alternative(s) Big pharmaceutical firm Dedicated biotechnology firm Department for Environment, Food and Rural Affairs Deoxyribonucleic acid Department of Trade and Industry European Food Safety Authority Engineering and Physical Sciences Research <strong>Council</strong> <strong>Emerging</strong> Science and Bioethics Advisory Committee Economic and Social Research <strong>Council</strong> (US) Food and Drug Administration Future <strong>Emerging</strong> Technologies Food Standards Agency Gross domestic product Genetically modified Genetically modified organism Gross national product GlaxoSmithKline Higher Education Funding <strong>Council</strong> for England Human embryonic stem cell Human Fertilisation and Embryology Authority Human Genetics Commission Human Genome Project 196
E m e r g i n g b i o t e c h n o l o g i e s HI HIF HIP ICT IPR IT ITRS IVF LMB MHRA MoD Health impact Health impact fund Health impact payment Information and communications technologies Intellectual property rights Information technologies International Technology Roadmap for Semiconductors In vitro fertilisation (Cambridge) Laboratory of Molecular Biology Medicines and Healthcare products Regulatory Agency Ministry of Defence L I S T O F A B B R E V I A T I O N S MRC NAS NEST NHS NSABB OECD PPP R&D REF RNA TRIPS TSB WHO Medical Research <strong>Council</strong> New active substance New and <strong>Emerging</strong> Science and Technologies National Health Service (US) National Science Advisory Board for Biosecurity Organisation for Economic Co-operation and Development Public private partnerships Research and development Research Excellence Framework Ribonucleic acid Agreement on Trade-Related Aspects of Intellectual Property Rights Technology Strategy Board World Health Organization 197
Page 1 and 2:
Emerging b
Page 3:
Emerging b
Page 6 and 7:
Secretariat Hugh Whittall (Director
Page 9:
Foreword 1 The use of living organi
Page 13:
Terms of reference 1. To examine co
Page 16 and 17:
Applying public ethics: towards a p
Page 19 and 20:
E m e r g i n g b i o t e c h n o l
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29:
Page 32 and 33:
Page 35:
Part 1 Understanding emerging <stro
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Chapter 2 Biotechnology promises an
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Chapter 3 The threefold challenge o
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 105 and 106:
Chapter 5 Public perspectives
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Chapter 6 Research
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177: E m e r g i n g b i o t e c h n o l
Page 181 and 182: Chapter 9 Commercialisation
Page 203 and 204: Chapter 10 Conclusions: emerging <s
Page 209 and 210: Appendices
Page 225: E m e r g i n g b i o t e c h n o l
Page 239: Previous Nuffield
show all

Emerging biotechnologies: full report - Nuffield Council on Bioethics

Create successful ePaper yourself

Delete template?

Save as template?